Nat-Abiraterone 250 mg

NAT-ABIRATERONE 250 MG tablets contain abiraterone acetate, a medication used in hormone therapy. This oral tablet is manufactured by Natco Pharma (Canada) Inc. and is commonly associated with prostate cancer treatment.

NAT-ABIRATERONE 250 MG tablets are primarily used in hormone therapy for conditions related to prostate cancer. Abiraterone acetate works by reducing androgen levels, which are hormones that can promote cancer growth. This medication is often prescribed as part of a broader treatment plan for advanced prostate cancer.

Common effects of NAT-ABIRATERONE 250 MG tablets may include fatigue, joint pain, and swelling. Some individuals might experience high blood pressure or changes in liver function. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

NAT-ABIRATERONE 250 MG tablets should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause harm to an unborn baby. Patients with liver problems should use this medication cautiously. Always follow the advice of a healthcare professional regarding the use of this medication.

NAT-ABIRATERONE 250 MG tablets may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. Alcohol and other substances that affect liver function should be avoided. It's crucial to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.